ES2149166T3 - Procedimiento de inmunoneutralizacion anti-lhrm de los animales domesticos machos no castrados y peptido para su realizacion. - Google Patents

Procedimiento de inmunoneutralizacion anti-lhrm de los animales domesticos machos no castrados y peptido para su realizacion.

Info

Publication number
ES2149166T3
ES2149166T3 ES92400496T ES92400496T ES2149166T3 ES 2149166 T3 ES2149166 T3 ES 2149166T3 ES 92400496 T ES92400496 T ES 92400496T ES 92400496 T ES92400496 T ES 92400496T ES 2149166 T3 ES2149166 T3 ES 2149166T3
Authority
ES
Spain
Prior art keywords
domestic animals
lhrm
castled
immunoneutralization
requested
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92400496T
Other languages
English (en)
Inventor
Raymond Dufour
Claude Roulet
Claire Chouvet
Michel Bernard Bonneau
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Animal Health France SAS
Boehringer Ingelheim Animal Health USA Inc
Original Assignee
Merial SAS
Merial Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26228546&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2149166(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from FR9102513A external-priority patent/FR2673377B1/fr
Priority claimed from FR9115289A external-priority patent/FR2685333B1/fr
Application filed by Merial SAS, Merial Inc filed Critical Merial SAS
Application granted granted Critical
Publication of ES2149166T3 publication Critical patent/ES2149166T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/23—Luteinising hormone-releasing hormone [LHRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0006—Contraceptive vaccins; Vaccines against sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6081—Albumin; Keyhole limpet haemocyanin [KLH]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Meat, Egg Or Seafood Products (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

EL PROCESO PARA MEJORAR LAS CUALIDADES ORGANOLEPTICAS, EN PARTICULAR EL OLOR, LA RAPIDEZ Y LA TERNURA, DE LA CARNE DE LOS ANIMALES DOMESTICOS MACHOS NO CASTRADOS, COMPRENDE, POCO ANTES DEL SACRIFICIO DEL ANIMAL EN CUESTION, LA SUPRESION DE LA ACCION DE LOS ESTEROIDES ANDROGENOS Y NO ANDROGENOS, POR INMUNONEUTRALIZACION ACTIVA O PASIVA ANTI-LHRH, A LA VEZ QUE SE MANTIENEN PRACTICAMENTE HASTA EL SACRIFICIO LAS VENTAJAS ASOCIADAS AL CARACTER MACHO DEL ANIMAL. LAS VACUNAS COMPRENDEN COMO PEPTIDO LA LHRH NATURAL O UN PEPTIDO DE FORMULA TRP-SER-TYR-GLY-LEU-ARG-PRO-GLY-NH SUB 2 -ACOPLADO A UNA PROTEINA PORTADORA INMUNOGENA.
ES92400496T 1991-03-01 1992-02-26 Procedimiento de inmunoneutralizacion anti-lhrm de los animales domesticos machos no castrados y peptido para su realizacion. Expired - Lifetime ES2149166T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9102513A FR2673377B1 (fr) 1991-03-01 1991-03-01 Procede pour ameliorer les qualites organoleptiques des animaux domestiques non castres.
FR9115289A FR2685333B1 (fr) 1991-12-10 1991-12-10 Nouveau peptide notamment pour la realisation de conjugues immunogenes anti-lhrh, vaccins les incorporant et ensemble de vaccination y relatif.

Publications (1)

Publication Number Publication Date
ES2149166T3 true ES2149166T3 (es) 2000-11-01

Family

ID=26228546

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92400496T Expired - Lifetime ES2149166T3 (es) 1991-03-01 1992-02-26 Procedimiento de inmunoneutralizacion anti-lhrm de los animales domesticos machos no castrados y peptido para su realizacion.

Country Status (19)

Country Link
US (1) US5573767A (es)
EP (1) EP0501882B1 (es)
JP (1) JP3177246B2 (es)
KR (1) KR100257214B1 (es)
AT (1) ATE194625T1 (es)
CA (1) CA2081660C (es)
CZ (1) CZ287775B6 (es)
DE (1) DE69231232T2 (es)
DK (1) DK0501882T3 (es)
ES (1) ES2149166T3 (es)
GR (1) GR3034509T3 (es)
HU (1) HU214453B (es)
IE (1) IE920648A1 (es)
PL (1) PL296623A1 (es)
PT (1) PT501882E (es)
SK (1) SK282056B6 (es)
TW (1) TW221674B (es)
UA (1) UA40570C2 (es)
WO (1) WO1992015330A1 (es)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5688506A (en) * 1994-01-27 1997-11-18 Aphton Corp. Immunogens against gonadotropin releasing hormone
US6761890B1 (en) * 1995-06-07 2004-07-13 Pepscan Systems B.V. Peptide, immunogenic composition and vaccine or medical preparation, a method to immunize animals against the hormone LHRH, and analogs of the LHRH tandem repeat peptide and their use as vaccine
CU22627A1 (es) * 1996-12-17 2000-12-22 Ct Ingenieria Genetica Biotech Preparado vacunal para la inmuno-castración reversible de mamíferos
AUPO776897A0 (en) * 1997-07-09 1997-07-31 Csl Limited A method of achieving production gains in livestock and agents useful for same
US6524592B2 (en) * 1997-10-17 2003-02-25 American Home Products Corporation Veterinary vaccines
US7790856B2 (en) 1998-04-07 2010-09-07 Janssen Alzheimer Immunotherapy Humanized antibodies that recognize beta amyloid peptide
US7964192B1 (en) 1997-12-02 2011-06-21 Janssen Alzheimer Immunotherapy Prevention and treatment of amyloidgenic disease
TWI239847B (en) * 1997-12-02 2005-09-21 Elan Pharm Inc N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease
US20080050367A1 (en) 1998-04-07 2008-02-28 Guriq Basi Humanized antibodies that recognize beta amyloid peptide
JP2002513770A (ja) * 1998-05-05 2002-05-14 メタモーフィックス，インコーポレイティド 食用獣肉生産のための動物を飼育する方法
ATE285806T1 (de) 1999-10-11 2005-01-15 Felton International Inc Universelle antiinfektionsschutzvorrichtung für nadellose injektoren
US6770054B1 (en) 1999-11-23 2004-08-03 Felton International, Inc. Injector assembly with driving means and locking means
US7887506B1 (en) 1999-11-23 2011-02-15 Pulse Needlefree Systems, Inc. Safety mechanism to prevent accidental patient injection and methods of same
MY139983A (en) 2002-03-12 2009-11-30 Janssen Alzheimer Immunotherap Humanized antibodies that recognize beta amyloid peptide
WO2003089590A2 (en) * 2002-04-16 2003-10-30 Vaxin, Inc. TRANSIENT AND/OR PERMANENT MODIFICATION OF SEXUAL BEHAVIOR AND/OR FERTILITY USING RECOMBINANT CHIMERIC GnRH
CN101791409A (zh) 2003-04-22 2010-08-04 研究及应用科学协会股份有限公司 肽载体
JP2005098877A (ja) * 2003-09-25 2005-04-14 Hitachi Software Eng Co Ltd 抗体検出体、その製造方法、及び抗体検出方法
WO2006026834A1 (en) * 2004-09-10 2006-03-16 The Council Of The Queensland Institute Of Medical Research (Qimr) Truncated lhrh formulations
EP1838348B1 (en) 2004-12-15 2013-06-26 Janssen Alzheimer Immunotherapy Humanized amyloid beta antibodies for use in improving cognition
KR100701550B1 (ko) * 2005-05-24 2007-03-30 한국과학기술연구원 베어링리스 스텝모터
US8784810B2 (en) 2006-04-18 2014-07-22 Janssen Alzheimer Immunotherapy Treatment of amyloidogenic diseases
JP5752343B2 (ja) * 2007-01-24 2015-07-22 株式会社ココカラファインネクスト Ｓ／ｏ型経皮免疫剤
US8003097B2 (en) 2007-04-18 2011-08-23 Janssen Alzheimer Immunotherapy Treatment of cerebral amyloid angiopathy
DK2182983T3 (da) 2007-07-27 2014-07-14 Janssen Alzheimer Immunotherap Behandling af amyloidogene sygdomme med humaniserede anti-abeta antistoffer
JO3076B1 (ar) 2007-10-17 2017-03-15 Janssen Alzheimer Immunotherap نظم العلاج المناعي المعتمد على حالة apoe
US9067981B1 (en) 2008-10-30 2015-06-30 Janssen Sciences Ireland Uc Hybrid amyloid-beta antibodies
US10920242B2 (en) 2011-02-25 2021-02-16 Recombinetics, Inc. Non-meiotic allele introgression
CA2837375C (en) 2011-06-01 2019-07-16 Merial Limited Needle-free administration of prrsv vaccines
AP2015008495A0 (en) * 2012-10-30 2015-05-31 Ct For Aquaculture Technologies Inc Control of sexual maturation in animals

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3780014A (en) 1971-09-16 1973-12-18 Abbott Lab Octapeptide intermediate to gonadotropin releasing hormone
US4018726A (en) * 1975-06-12 1977-04-19 Andrew Victor Schally [D-Phe6 ]-LH-RH and intermediates therefor
US4010125A (en) * 1975-06-12 1977-03-01 Schally Andrew Victor [D-Trp6 ]-LH-RH and intermediates therefor
US4024121A (en) * 1976-01-27 1977-05-17 Schally Andrew Victor (Pyro)-Glu-His-Trp-D-Ser-Tyr-D-Leu-Leu-Arg-Pro-NHR and intermediates
US4770874A (en) * 1983-08-22 1988-09-13 Syntex (U.S.A.) Inc. Polyoxypropylene-polyoxyethylene block polymer based adjuvants
US4676981A (en) * 1984-02-07 1987-06-30 University Of Saskatchewan Monoclonal antibodies against GnRH
US4608251A (en) * 1984-11-09 1986-08-26 Pitman-Moore, Inc. LHRH analogues useful in stimulating anti-LHRH antibodies and vaccines containing such analogues
US4556555A (en) * 1985-01-25 1985-12-03 North Carolina State University Process for the immunological neutering of animals
IL78775A (en) * 1985-05-15 1992-06-21 Biotech Australia Pty Ltd Oral vaccines
NZ220932A (en) * 1986-07-03 1990-05-28 Victoria State Composition comprising an antigenic substance, such as lhrh, conjugated to at least two different carriers and method of immunological castration and spaying
EP0282501A4 (en) * 1986-08-18 1989-11-14 Bunge Australia REGULATION OF ANIMAL REPRODUCTION.
AU602187B2 (en) * 1987-01-14 1990-10-04 Commonwealth Scientific And Industrial Research Organisation Anti-reproductive hormone
GB8713240D0 (en) * 1987-06-05 1987-07-08 Proteus Biotech Ltd Hormones
US4975420A (en) * 1987-09-30 1990-12-04 University Of Saskatchewan Agents and procedures for provoking an immune response to GnRH and immuno sterilizing mammals
US5036047A (en) * 1988-09-29 1991-07-30 Pitman-Moore, Inc. Method and composition for preventing conception
US5484592A (en) * 1989-03-23 1996-01-16 Stitching Centraal Diergeneeskundig Instituut Peptide, immunogenic composition and vaccine or medicinal preparation: a method of immunising a mammal against LHRH, and a method of improving the meat quality of pigs
NL8900726A (nl) * 1989-03-23 1990-10-16 Stichting Centr Diergeneeskund Peptide, immunogene samenstelling en vaccin- of geneesmiddelpreparaat; werkwijze voor het immuniseren van een zoogdier tegen lhrh, en werkwijze voor het verbeteren van de vleeskwaliteit van varkens.

Also Published As

Publication number Publication date
UA40570C2 (uk) 2001-08-15
PT501882E (pt) 2000-12-29
SK328092A3 (en) 1995-01-12
IE920648A1 (en) 1992-09-09
US5573767A (en) 1996-11-12
CA2081660C (en) 2001-05-01
GR3034509T3 (en) 2000-12-29
WO1992015330A1 (fr) 1992-09-17
JPH05506459A (ja) 1993-09-22
HUT63338A (en) 1993-08-30
SK282056B6 (sk) 2001-10-08
DK0501882T3 (da) 2000-12-11
KR100257214B1 (ko) 2000-05-15
DE69231232T2 (de) 2001-01-04
ATE194625T1 (de) 2000-07-15
CZ328092A3 (en) 1993-10-13
CZ287775B6 (cs) 2001-01-17
CA2081660A1 (en) 1992-09-02
DE69231232D1 (de) 2000-08-17
JP3177246B2 (ja) 2001-06-18
TW221674B (es) 1994-03-11
HU214453B (hu) 1998-03-30
HU9203419D0 (en) 1993-01-28
EP0501882A2 (fr) 1992-09-02
EP0501882A3 (en) 1992-10-14
PL296623A1 (en) 1993-09-20
EP0501882B1 (fr) 2000-07-12

Similar Documents

Publication Publication Date Title
ES2149166T3 (es) Procedimiento de inmunoneutralizacion anti-lhrm de los animales domesticos machos no castrados y peptido para su realizacion.
MX9604907A (es) Vacuna de combinacion de virus para la enfermedad de newcastle.
AU7814498A (en) Multivalent (in ovo) avian vaccine
GR3035941T3 (en) Vaccine adjuvants
KR937000146A (ko) 거세되지 않은 수컷 가축의 고기의 관능적 품질을 개선하기 위한 방법, 이 방법에 이용 가능한 백신, 특히 그 백신을 생산하기 위한 신규의 펩티드 및 그에 관계된 백신반응 키트
BG100642A (bg) Ваксиниране in оvо срещу кокцидиоза
SU1135424A3 (ru) Способ убо животных
DE3867119D1 (de) Verfahren zum betaeuben von lungenatmenden schlachttieren.
AU5913096A (en) An improved peptide, immunogenic composition and vaccine or medical preparation, a method to immunise animals against the hormone LHRH, and analogs of the LHRH tandem repeat peptide and their use as vaccine
EP0547102A4 (es)
DK0626008T3 (da) Vaccine, der som en adjuvans indeholder acemannan
TAUSSIG Antigenic competition
NZ228232A (en) Live combined vaccine comprising at least one live infectious bronchitis virus and at least one other virus infectious to poultry
Ülker et al. Feedlot performance and carcass characteristics of ram lambs immunized against recombinant LHRH fusion proteins at 10 weeks of age
GB2246501A (en) Meat pre-tenderisation
EP2431052A1 (en) Protein for the immunocastration for mammals
Kirk Selective scar revision & elective incision techniques applicable to the legs of horses. Part I. Application of adjacent Z-plasty adjunct procedure in the repair of skin wounds on the lower legs of horses
GB2174298A (en) Increasing the sexual activity of birds and domestic mammals
RU94036412A (ru) Вакцина для подавления половой функции млекопитающих
SU1405300A1 (ru) Штамм бактерий chlamydia psittaci, используемый для изготовления инактивированной вакцины против хламидиоза свиней
RO100738A2 (ro) Procedeu de preparare a vaccinului inactivat uleios, contra bursitei infectioase aviare
BG100932A (en) Method for the preparation of cellular cultural inactivated vaccine against fowl pest
RU96123906A (ru) Способ и вакцина для профилактики и лечения иммунодефицитов, например рака
RU99117507A (ru) Кормовая добавка и способ ее использования

Legal Events

Date Code Title Description
FC2A Grant refused

Effective date: 19940617

FG2A Definitive protection

Ref document number: 501882

Country of ref document: ES